Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 18 studies | 52% ± 13% | |
lung | 17 studies | 41% ± 13% | |
brain | 17 studies | 32% ± 17% | |
intestine | 11 studies | 32% ± 14% | |
eye | 10 studies | 38% ± 15% | |
kidney | 8 studies | 32% ± 10% | |
lymph node | 5 studies | 45% ± 7% | |
liver | 5 studies | 43% ± 18% | |
pancreas | 4 studies | 44% ± 17% | |
bone marrow | 4 studies | 41% ± 15% | |
heart | 4 studies | 23% ± 5% | |
uterus | 4 studies | 53% ± 15% | |
breast | 4 studies | 39% ± 8% | |
adipose | 4 studies | 30% ± 9% | |
placenta | 3 studies | 42% ± 8% | |
prostate | 3 studies | 38% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 8413.30 | 1445 / 1445 | 100% | 71.46 | 183 / 183 |
ovary | 100% | 17434.52 | 180 / 180 | 100% | 39.65 | 430 / 430 |
prostate | 100% | 12108.03 | 245 / 245 | 100% | 51.73 | 502 / 502 |
breast | 100% | 10725.83 | 459 / 459 | 100% | 42.71 | 1116 / 1118 |
bladder | 100% | 9276.14 | 21 / 21 | 100% | 37.64 | 503 / 504 |
uterus | 100% | 15820.19 | 170 / 170 | 100% | 42.88 | 458 / 459 |
lung | 100% | 8834.19 | 578 / 578 | 100% | 42.12 | 1152 / 1155 |
stomach | 100% | 6435.50 | 359 / 359 | 100% | 45.15 | 285 / 286 |
intestine | 100% | 9728.82 | 966 / 966 | 100% | 38.58 | 525 / 527 |
thymus | 100% | 9519.44 | 653 / 653 | 99% | 38.21 | 600 / 605 |
skin | 100% | 10310.97 | 1809 / 1809 | 99% | 40.74 | 468 / 472 |
brain | 99% | 6563.67 | 2606 / 2642 | 100% | 34.85 | 705 / 705 |
pancreas | 100% | 4089.88 | 327 / 328 | 99% | 33.17 | 176 / 178 |
kidney | 100% | 5501.19 | 89 / 89 | 97% | 27.67 | 877 / 901 |
adrenal gland | 100% | 6444.54 | 258 / 258 | 96% | 20.21 | 220 / 230 |
liver | 100% | 3316.87 | 226 / 226 | 91% | 15.25 | 369 / 406 |
adipose | 100% | 9065.46 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 38.13 | 29 / 29 |
muscle | 100% | 6948.11 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 9128.52 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 40.70 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 9.50 | 1 / 1 |
blood vessel | 100% | 8713.19 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 98% | 5452.85 | 845 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 98% | 23.64 | 78 / 80 |
peripheral blood | 82% | 5006.22 | 766 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0000398 | Biological process | mRNA splicing, via spliceosome |
GO_0008380 | Biological process | RNA splicing |
GO_0000375 | Biological process | RNA splicing, via transesterification reactions |
GO_0048024 | Biological process | regulation of mRNA splicing, via spliceosome |
GO_0016363 | Cellular component | nuclear matrix |
GO_0016607 | Cellular component | nuclear speck |
GO_0071013 | Cellular component | catalytic step 2 spliceosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005681 | Cellular component | spliceosomal complex |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0005515 | Molecular function | protein binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | SRRM1 |
Protein name | Serine and arginine repetitive matrix 1 (Serine/arginine repetitive matrix 1 isoform 2) Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein) Serine/arginine repetitive matrix 1 isoform 1 (Serine/arginine repetitive matrix 1, isoform CRA_a) Serine and arginine repetitive matrix 1 |
Synonyms | hCG_96287 SRM160 |
Description | FUNCTION: Part of pre- and post-splicing multiprotein mRNP complexes. As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs (Probable). Involved in numerous pre-mRNA processing events. Promotes constitutive and exonic splicing enhancer (ESE)-dependent splicing activation by bridging together sequence-specific (SR family proteins, SFRS4, SFRS5 and TRA2B/SFRS10) and basal snRNP (SNRP70 and SNRPA1) factors of the spliceosome. Stimulates mRNA 3'-end cleavage independently of the formation of an exon junction complex. Binds both pre-mRNA and spliced mRNA 20-25 nt upstream of exon-exon junctions. Binds RNA and DNA with low sequence specificity and has similar preference for either double- or single-stranded nucleic acid substrates. . |
Accessions | Q8IYB3 ENST00000705663.1 ENST00000374389.8 M0R088 A9Z1X7 M0QXG5 ENST00000705662.1 ENST00000600523.5 A0A994J7H1 M0R1E7 A0A0S2Z4Z6 A0A994J7V4 ENST00000323848.14 [Q8IYB3-1] ENST00000705681.1 ENST00000705682.1 A0A0S2Z4W1 A0A994J4Y3 ENST00000593639.5 ENST00000596378.1 |